Back to results
US 10,946,049 B2Granted
Use of gram negative species to treat atopic dermatitis
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsIan Antheni Myles, Sandip K. Datta
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions are disclosed that includes a therapeutically effective amount of a purified viable Gram negative bacteria and a pharmaceutically acceptable carrier. The pharmaceutical compositions are formulated for topical administration. Methods of treating atopic dermatitis using these pharmaceutical compositions are also disclosed.
Claims8
A pharmaceutical composition, wherein the pharmaceutical composition comprises:
- at least one strain of Roseomonas mucosa, wherein the at least one strain of Roseomonas mucosa is a viable, skin commensal organism present in an amount sufficient for reducing growth of Staphylococcus aureus on skin of a subject in need thereof, and wherein the pharmaceutical composition is formulated in a topical dosage form selected from the group consisting of a cream, gel, foam, ointment, and a lotion.
Dependencies are inferred from the claim text.